Trials / Completed
CompletedNCT07053839
Effect of a Daily Text Reminder on Asthma Medication Use, Symptom Control, and Lung Function in Children
Effect of the Visual Reminder "AdhasText" on Adherence to Inhaled Corticosteroids, Symptom Control, and Pulmonary Function in Children With Asthma: A Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- ROXANA AZNARAN TORRES · Academic / Other
- Sex
- All
- Age
- 5 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn if a daily text reminder ("AdhasText") can help children with asthma use their inhalers regularly, control their symptoms, and improve their lung function. The main questions it aims to answer are: Does the daily text reminder improve adherence to inhaled corticosteroids in children with asthma? Does the text reminder help children with asthma control their symptoms better? Does the text reminder improve lung function in children with asthma? Researchers will compare children who receive the daily text reminder with usual care to children who receive usual care (without the reminder) to see if the text reminder improves adherence, symptom control, and lung function. Participants will: Receive a daily text reminder or usual care (no reminder) for 90 days Complete questionnaires about their asthma symptoms at 45 and 90 days Have spirometry tests to measure lung function at the start of the study and 90 days
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Daily Text Reminder | The intervention, titled "AdhasText," involved sending a daily SMS reminder to caregivers, specifically mothers of children with asthma. The message, "If you want to stay healthy, you must use your inhaler," was sent at 7:00 p.m. over a 90 days period. |
Timeline
- Start date
- 2023-07-22
- Primary completion
- 2024-09-30
- Completion
- 2024-09-30
- First posted
- 2025-07-08
- Last updated
- 2025-07-08
Locations
1 site across 1 country: Peru
Source: ClinicalTrials.gov record NCT07053839. Inclusion in this directory is not an endorsement.